| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.1 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.088 | 0.1 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.089 | 0.1 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |